UiPath, Inc. (NYSE:PATH - Get Free Report) CEO Daniel Dines sold 45,000 shares of the business's stock in a transaction on Wednesday, October 22nd. The stock was sold at an average price of $15.53, for a total transaction of $698,850.00. Following the transaction, the chief executive officer directly owned 29,738,585 shares in the company, valued at $461,840,225.05. This trade represents a 0.15% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink.
Daniel Dines also recently made the following trade(s):
- On Monday, October 20th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $15.71, for a total transaction of $706,950.00.
- On Friday, October 17th, Daniel Dines sold 45,000 shares of UiPath stock. The shares were sold at an average price of $15.62, for a total transaction of $702,900.00.
- On Wednesday, October 15th, Daniel Dines sold 122,734 shares of UiPath stock. The shares were sold at an average price of $16.92, for a total transaction of $2,076,659.28.
- On Monday, October 13th, Daniel Dines sold 122,734 shares of UiPath stock. The stock was sold at an average price of $17.06, for a total transaction of $2,093,842.04.
- On Friday, October 10th, Daniel Dines sold 122,734 shares of UiPath stock. The stock was sold at an average price of $18.37, for a total transaction of $2,254,623.58.
- On Wednesday, October 8th, Daniel Dines sold 122,734 shares of UiPath stock. The stock was sold at an average price of $14.89, for a total transaction of $1,827,509.26.
- On Monday, October 6th, Daniel Dines sold 122,733 shares of UiPath stock. The stock was sold at an average price of $14.24, for a total transaction of $1,747,717.92.
- On Wednesday, October 1st, Daniel Dines sold 122,733 shares of UiPath stock. The stock was sold at an average price of $13.33, for a total transaction of $1,636,030.89.
- On Monday, September 29th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $12.33, for a total transaction of $1,513,297.89.
- On Friday, September 26th, Daniel Dines sold 122,733 shares of UiPath stock. The shares were sold at an average price of $12.08, for a total transaction of $1,482,614.64.
UiPath Stock Performance
UiPath stock traded down $1.27 during trading hours on Wednesday, reaching $15.02. 27,800,191 shares of the company's stock traded hands, compared to its average volume of 14,363,829. The firm has a market capitalization of $7.97 billion, a price-to-earnings ratio of 500.50, a PEG ratio of 5.89 and a beta of 1.07. The firm's 50 day moving average is $12.75 and its 200-day moving average is $12.31. UiPath, Inc. has a fifty-two week low of $9.38 and a fifty-two week high of $18.74.
UiPath (NYSE:PATH - Get Free Report) last announced its quarterly earnings results on Thursday, September 4th. The company reported $0.15 EPS for the quarter, beating analysts' consensus estimates of $0.08 by $0.07. UiPath had a return on equity of 1.28% and a net margin of 1.35%.The company had revenue of $361.73 million during the quarter, compared to analysts' expectations of $347.36 million. During the same period in the prior year, the business posted $0.04 EPS. UiPath's revenue was up 14.6% on a year-over-year basis. UiPath has set its FY 2026 guidance at EPS. Q3 2026 guidance at EPS. Analysts predict that UiPath, Inc. will post -0.17 EPS for the current year.
Analyst Ratings Changes
PATH has been the subject of several recent analyst reports. Cowen reissued a "hold" rating on shares of UiPath in a report on Friday, September 5th. DA Davidson initiated coverage on UiPath in a report on Friday, September 5th. They issued a "neutral" rating and a $12.00 price objective for the company. BMO Capital Markets increased their price objective on UiPath from $12.50 to $13.00 and gave the company a "market perform" rating in a report on Thursday, October 2nd. Truist Financial cut their price target on UiPath from $13.00 to $12.00 and set a "hold" rating for the company in a report on Friday, September 5th. Finally, Zacks Research raised UiPath from a "hold" rating to a "strong-buy" rating in a report on Monday, September 8th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, twelve have assigned a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $13.21.
Get Our Latest Stock Analysis on PATH
Institutional Inflows and Outflows
Hedge funds have recently modified their holdings of the stock. Hudson Bay Capital Management LP bought a new position in UiPath in the second quarter valued at about $102,559,000. Norges Bank bought a new position in UiPath in the second quarter valued at about $68,451,000. AQR Capital Management LLC grew its position in UiPath by 76.0% in the second quarter. AQR Capital Management LLC now owns 11,407,569 shares of the company's stock valued at $145,732,000 after acquiring an additional 4,926,341 shares during the last quarter. TFG Asset Management GP Ltd grew its holdings in shares of UiPath by 53.3% during the second quarter. TFG Asset Management GP Ltd now owns 13,722,244 shares of the company's stock worth $175,645,000 after purchasing an additional 4,772,244 shares during the last quarter. Finally, Federated Hermes Inc. grew its holdings in shares of UiPath by 479.3% during the first quarter. Federated Hermes Inc. now owns 5,720,096 shares of the company's stock worth $58,917,000 after purchasing an additional 4,732,712 shares during the last quarter. Institutional investors own 62.50% of the company's stock.
UiPath Company Profile
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.